Related Experiment Video
Updated: Jan 20, 2026

Visualizing Scar Development Using SCAD Assay - An Ex-situ Skin Scarring Assay
Published on: April 28, 2022
[Secondary surgical and medical treatment of scars]
1Carré esthétique Lafayette, 5, place Aristide-Briand, 44000 Nantes, France.
Abstract:
The authors, through their experience, take stock of current secondary management of scars whether they are pathological (hypertrophic, cheloid) or dystrophic (enlarged, hypo- or hyper-pigmented, adherent) by presenting surgical or medical solutions.
Related Concept Videos
07:40Visualizing Scar Development Using SCAD Assay - An Ex-situ Skin Scarring Assay
05:54A Mouse Model of Mechanotransduction-driven, Human-like Hypertrophic Scarring
04:34Surgical Treatment of an Endolymphatic Sac Tumor
Preparing and Administering Secondary Intermittent Intravenous Medications
Secondary intravenous (IV) infusions are a way to administer smaller volume-controlled amounts of IV solution (25-250 mL). Secondary IV infusions are delivered over longer periods of time than IV push medications, which reduces the risks associated with rapid infusions, such as phlebitis and infiltration. In addition, some antibiotic medications are only stable for a limited time in...
08:20In Vitro Model of Human Cutaneous Hypertrophic Scarring using Macromolecular Crowding
06:23Diagnosis and Surgical Treatment of Human Brucellar Spondylodiscitis

